Sonendo (SONX) Competitors

$0.50 0.00 (0.00%)

As of 05/4/2026

SONX vs. PAVM, TNON, SINT, NXL, and NVNO

Should you be buying Sonendo stock or one of its competitors? The main competitors of Sonendo include PAVmed (PAVM), Tenon Medical (TNON), Sintx Technologies (SINT), Nexalin Technology (NXL), and enVVeno Medical (NVNO). These companies are all part of the "medical equipment" industry.

How does Sonendo compare to PAVmed?

Sonendo (NYSE:SONX) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

: PAVmed has lower revenue, but higher earnings than Sonendo. PAVmed is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonendo $44.40M 0.05 -$60.92M -$71.12 N/A
PAVmed $70K 115.00 $400K -$22.77 N/A
: In the previous week, PAVmed had 3 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for PAVmed and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 equaled PAVmed'saverage media sentiment score.
Company Overall Sentiment
Sonendo Neutral
PAVmed Neutral
: PAVmed has a consensus price target of $65.00, suggesting a potential upside of 707.45%. Given PAVmed's stronger consensus rating and higher probable upside, analysts plainly believe PAVmed is more favorable than Sonendo.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonendo
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
PAVmed
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: PAVmed has a net margin of 564.79% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat PAVmed's return on equity.
Company Net Margins Return on Equity Return on Assets
Sonendo -92.74% -184.01% -68.60%
PAVmed 564.79% -242.99% -17.25%
: 28.7% of Sonendo shares are owned by institutional investors. Comparatively, 19.9% of PAVmed shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 5.8% of PAVmed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: Sonendo has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500. Comparatively, PAVmed has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.05	-$60.92M	-$71.12	N/A
PAVmed	$70K	115.00	$400K	-$22.77	N/A

Company	Overall Sentiment
Sonendo	Neutral
PAVmed	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
PAVmed	564.79%	-242.99%	-17.25%

Summary

PAVmed beats Sonendo on 9 of the 15 factors compared between the two stocks.

How does Sonendo compare to Tenon Medical?

Sonendo (NYSE:SONX) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

: In the previous week, Tenon Medical had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for Tenon Medical and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 equaled Tenon Medical'saverage media sentiment score.
Company Overall Sentiment
Sonendo Neutral
Tenon Medical Neutral
: 28.7% of Sonendo shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 7.9% of Sonendo shares are held by insiders. Comparatively, 0.3% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
: Sonendo has a net margin of -92.74% compared to Tenon Medical's net margin of -318.36%. Sonendo's return on equity of -184.01% beat Tenon Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Sonendo -92.74% -184.01% -68.60%
Tenon Medical -318.36% -409.16% -110.06%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonendo
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Tenon Medical
1 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Tenon Medical has lower revenue, but higher earnings than Sonendo. Tenon Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonendo $44.40M 0.05 -$60.92M -$71.12 N/A
Tenon Medical $3.94M 2.13 -$12.56M -$1.99 N/A
: Sonendo has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Company	Overall Sentiment
Sonendo	Neutral
Tenon Medical	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Tenon Medical	-318.36%	-409.16%	-110.06%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.05	-$60.92M	-$71.12	N/A
Tenon Medical	$3.94M	2.13	-$12.56M	-$1.99	N/A

Summary

Sonendo beats Tenon Medical on 8 of the 14 factors compared between the two stocks.

How does Sonendo compare to Sintx Technologies?

Sonendo (NYSE:SONX) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

: Sintx Technologies has a consensus target price of $11.00, suggesting a potential upside of 354.55%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Sonendo.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonendo
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Sintx Technologies
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.33
: In the previous week, Sonendo's average media sentiment score of 0.00 equaled Sintx Technologies'average media sentiment score.
Company Overall Sentiment
Sonendo Neutral
Sintx Technologies Neutral
: 28.7% of Sonendo shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
: Sonendo has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
: Sonendo has a net margin of -92.74% compared to Sintx Technologies' net margin of -1,018.08%. Sonendo's return on equity of -184.01% beat Sintx Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Sonendo -92.74% -184.01% -68.60%
Sintx Technologies -1,018.08% -242.76% -99.86%
: Sintx Technologies has lower revenue, but higher earnings than Sonendo. Sintx Technologies is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonendo $44.40M 0.05 -$60.92M -$71.12 N/A
Sintx Technologies $1.02M 9.77 -$10.36M -$5.66 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Company	Overall Sentiment
Sonendo	Neutral
Sintx Technologies	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Sintx Technologies	-1,018.08%	-242.76%	-99.86%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.05	-$60.92M	-$71.12	N/A
Sintx Technologies	$1.02M	9.77	-$10.36M	-$5.66	N/A

Summary

Sonendo beats Sintx Technologies on 8 of the 14 factors compared between the two stocks.

How does Sonendo compare to Nexalin Technology?

Sonendo (NYSE:SONX) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

: Sonendo has a net margin of -92.74% compared to Nexalin Technology's net margin of -2,722.19%. Sonendo's return on equity of -184.01% beat Nexalin Technology's return on equity.
Company Net Margins Return on Equity Return on Assets
Sonendo -92.74% -184.01% -68.60%
Nexalin Technology -2,722.19% -195.69% -171.05%
: In the previous week, Nexalin Technology's average media sentiment score of 0.31 beat Sonendo's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the news media.
Company Overall Sentiment
Sonendo Neutral
Nexalin Technology Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonendo
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Nexalin Technology
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Nexalin Technology has lower revenue, but higher earnings than Sonendo. Nexalin Technology is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonendo $44.40M 0.05 -$60.92M -$71.12 N/A
Nexalin Technology $300K 24.70 -$8.22M -$0.51 N/A
: 28.7% of Sonendo shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
: Sonendo has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.56, suggesting that its share price is 256% more volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Nexalin Technology	-2,722.19%	-195.69%	-171.05%

Company	Overall Sentiment
Sonendo	Neutral
Nexalin Technology	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.05	-$60.92M	-$71.12	N/A
Nexalin Technology	$300K	24.70	-$8.22M	-$0.51	N/A

Summary

Nexalin Technology beats Sonendo on 7 of the 13 factors compared between the two stocks.

How does Sonendo compare to enVVeno Medical?

Sonendo (NYSE:SONX) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

: enVVeno Medical has lower revenue, but higher earnings than Sonendo. enVVeno Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonendo $44.40M 0.05 -$60.92M -$71.12 N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonendo
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50
: In the previous week, Sonendo's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
Sonendo Neutral
enVVeno Medical Neutral
: enVVeno Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. enVVeno Medical's return on equity of -60.88% beat Sonendo's return on equity.
Company Net Margins Return on Equity Return on Assets
Sonendo -92.74% -184.01% -68.60%
enVVeno Medical N/A -60.88% -56.01%
: 28.7% of Sonendo shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: Sonendo has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.05	-$60.92M	-$71.12	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Company	Overall Sentiment
Sonendo	Neutral
enVVeno Medical	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
enVVeno Medical	N/A	-60.88%	-56.01%

Summary

enVVeno Medical beats Sonendo on 8 of the 11 factors compared between the two stocks.

Get Sonendo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SONX vs. The Competition

Export

Metric	Sonendo	Dental equipment & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$2.39M	$1.40M	$6.25B	$22.85B
Dividend Yield	N/A	N/A	2.74%	4.06%
P/E Ratio	-0.01	N/A	24.91	25.44
Price / Sales	0.05	0.03	504.56	24.24
Price / Cash	N/A	N/A	43.30	25.18
Price / Book	0.01	0.01	9.67	5.37
Net Income	-$60.92M	-$73.66M	$3.55B	$1.07B
7 Day Performance	N/A	51.52%	1.70%	0.89%
1 Month Performance	51.52%	51.52%	5.62%	6.56%
1 Year Performance	-56.14%	-56.14%	34.42%	31.66%

Sonendo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SONX Sonendo	N/A	$0.50 flat	N/A	N/A	$2.39M	$44.40M	N/A	250	Upcoming Earnings
PAVM PAVmed	2.1498 of 5 stars	$8.30 -7.0%	$65.00 +683.1%	N/A	$8.88M	$70K	N/A	90	Gap Down High Trading Volume
TNON Tenon Medical	0.0581 of 5 stars	$0.76 -0.1%	N/A	N/A	$8.64M	$3.94M	N/A	8	Positive News Upcoming Earnings
SINT Sintx Technologies	3.1462 of 5 stars	$2.11 +6.0%	$11.00 +421.3%	N/A	$8.20M	$1.02M	N/A	40	Positive News High Trading Volume
NXL Nexalin Technology	0.2534 of 5 stars	$0.36 +2.4%	N/A	N/A	$7.14M	$300K	N/A	3

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SONX) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonendo (SONX) Competitors

SONX vs. PAVM, TNON, SINT, NXL, and NVNO

How does Sonendo compare to PAVmed?

Summary

How does Sonendo compare to Tenon Medical?

Summary

How does Sonendo compare to Sintx Technologies?

Summary

How does Sonendo compare to Nexalin Technology?

Summary

How does Sonendo compare to enVVeno Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sonendo (SONX) Competitors

SONX vs. PAVM, TNON, SINT, NXL, and NVNO

How does Sonendo compare to PAVmed?

Summary

How does Sonendo compare to Tenon Medical?

Summary

How does Sonendo compare to Sintx Technologies?

Summary

How does Sonendo compare to Nexalin Technology?

Summary

How does Sonendo compare to enVVeno Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools